NCT06137794

Application of "I-Anticoagulation"in Patients With Atrial Fibrillation

Application of the Anticoagulation Decision-making and Management Model Based on the "I-Anticoagulation" Tool in Patients With Atrial Fibrillation: A Prospective, Multicenter, Cluster Randomized Controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 440 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The goal of this prospective, multicenter, cluster randomized controlled trial is to assess the effectiveness of a shared decision-making tool, "I-Anticoagulation", for anticoagulation management in AF patients. The main questions it aims to answer are: * whether "I-Anticoagulation" could help improve the rational use of anticoagulants in AF patients; * whether "I-Anticoagulation" could help increase the adherence and satisfaction of AF patients receiving anticoagulants. The anticoagulation therapy of AF patients will be determined by clinicians with the use of "I-Anticoagulation", and AF patients will be managed using "I-Anticoagulation" during their anticoagulation therapy. Researchers will compare the outcomes with the control group, in which patients with AF will receive standard care.

Conditions

• Atrial Fibrillation
• Anticoagulants

Interventions

Type	Name	Description
OTHER	Use of "I-Anticoagulation" to make the decision and manage patients	I-Anticoagulation will offer a flexible and efficient communication platform for healthcare professionals and AF patients. The tool is composed of two modules: an anticoagulation decision support system and a full-process patient management system.

Timeline

• Start date: 2023-11-15
• Primary completion: 2024-12-31
• Completion: 2025-06-30
• First posted: 2023-11-18
• Last updated: 2023-11-18